Clinical use of Iscador® Complementary CancerTreatment Over 90 years ago, Iscador®, an extract from the mistletoe plant (Viscum Album), was virtually unknown in Europe. Today, thanks to ongoing scientific investigation and refinement, it is the most frequently used of all the mistletoe cancer treatments in the world. Iscador® behaves in a number of complex ways, but it is now recognized that one of its primary functions is that it stimulates parts of the immune system that can slow the growth of cancer cells, and does so with very limited side effects. For this reason, it is often used in conjunction with conventional therapies such as surgery, chemo and radio therapies. Seminar Objectives This one-day seminar will review the current research and application of Iscador®, as an effective and clinically-proven complementary cancer treatment. Participants will receive the information necessary to start implementing the use of Iscador® in their practice or deepen their knowledge of the treatment. Key Clinical Takeaways This seminar will highlight the history of mistletoe and its development as Iscador® , production methods, treatment benefits and practical application, clinical research and case studies.